RBC Capital upgraded Bio-Techne (TECH) to Outperform from Sector Perform with a $73 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TECH:
- CoreWeave upgraded, Instacart downgraded: Wall Street’s top analyst calls
- Bio-Techne upgraded to Buy from Neutral at Citi
- Strategic Divestiture and Focus on Core Strengths Justify Buy Rating for Bio-Techne
- Bio-Techne’s Strong Q4 Performance and Strategic Moves Justify Buy Rating
- Bio-Techne Reports Solid Q4 2025 Results Amid Strategic Shift